Catalyst Wire Dossier Catalyst Wire Dossier

Gemcitabine with oxaliplatin (GEMOX)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gemcitabine with oxaliplatin (GEMOX), covering 2022-08-26 to 2022-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Gemcitabine With Oxaliplatin (GEMOX) in Patients With Advanced Hepatocellular Carcinoma After Failure of Sorafenib Treatment [Phase 2]

See pricing